EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Enzo Biochem's enterprise value is $1.24 Mil.
Enzo Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $-2.75 Mil. Therefore, Enzo Biochem's EV-to-EBITDA for today is -0.45.
The historical rank and industry rank for Enzo Biochem's EV-to-EBITDA or its related term are showing as below:
ENZ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -10439.1 Med: -6.59 Max: 1238.77
Current: -0.45
During the past 13 years, the highest EV-to-EBITDA of Enzo Biochem was 1238.77. The lowest was -10439.10. And the median was -6.59.
ENZ's EV-to-EBITDA is ranked worse than 100% of 117
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.81
vs ENZ: -0.45
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Enzo Biochem EV-to-EBITDA Historical Data
The historical data trend for Enzo Biochem's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's EV-to-EBITDA
For the Diagnostics & Research subindustry, Enzo Biochem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's EV-to-EBITDA falls into.
Enzo Biochem EV-to-EBITDA Calculation
Enzo Biochem's EV-to-EBITDA for today is calculated as:
Enzo Biochem's current Enterprise Value is $1.24 Mil.
Enzo Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enzo Biochem (NYSE:ENZ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Enzo Biochem's PE Ratio for today is calculated as:
Enzo Biochem's share price for today is $1.07.
Enzo Biochem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.670.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Enzo Biochem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 